Electromed, Inc. (ELMD)

From the record

Electromed, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Electromed, Inc.'s 9 filed years say what it did: revenue went from $28 million in fiscal 2018 to $74 million in fiscal 2026, up 12.7% a year; it rose in 8 of 8 years; it never fell from a peak; net income was positive in 9 of 9 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2026-06-30, Electromed, Inc.'s diluted share count held steady, and dividends and buybacks returned about 47% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 9 sales and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2026-06-30, Electromed, Inc. earned about 21 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 87 cents per dollar of everything the company owns. Leverage: it owed about 19 cents per dollar of assets, and net share issuance: its share count shrank 2.5% over the year (the filed statements).

From the record

Electromed, Inc.'s standing among 24 graded names in its industry family: revenue of $74 million in fiscal 2026 ranks in the top 44% by size; a net margin of 15.3% ranks in the top 10%; revenue growth of 15.3% a year over the last 3 filed years ranks in the top 30% (its annual reports).

From the record

Electromed, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Cunniff, James L. (CEO and President, as filed), filing under that title since 2023-07-05, 3.4 years (top 36% of its family); the 9 officers and directors filing in the last fifteen months have been on the record a median of 5 years (top 38%); 1 officer or director change was reported on Form 8-K since 2023-11-13, against the 9 people in charge now (top 6%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Electromed, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $20 million against no long-term debt tagged leaves 30.9% of its assets as net cash, top 29% of its family; cash from operations less capital spending is 11.4% of revenue (top 20%); a gross margin of 78.5% (top 20%); research spending of 1.8% of revenue (bottom 2%) (its annual report).

From the record

Electromed, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew 15.3% a year over the last three filed years against 12.7% over all 9, speeding up (top 33% of its family); the newest year grew 15.3% (top 50%); research spending grew 12.8% a year (top 34%); capital spending grew -8.8% a year (bottom 40%) (its annual reports). Electromed, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Electromed, Inc.'s newest year against its own record: revenue of $74 million in fiscal 2026 came in 0.1% below the $74 million its prior three years' pace pointed to (bottom 40% of its family); net income of $11 million against a prior three-year average of $5 million (top 7%); a net margin of 15.3% against 9.3% before (bottom 48%) (its annual reports).